HESA Committee Report

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

PDF

APPENDIX C:

LIST OF WITNESSES

Organizations and Individuals		Date		Meeting

AMGEN Canada Inc. Daniel Billen, Vice-President and General Manager	2007/04/16		47

BIOTECanada Peter Brenders, President and Chief Executive Officer Sean Thompson, Director, Corporate Development, YM Biosciences Inc.

Canada's Research-Based Pharmaceutical Companies (Rx & D) Mark Ferdinand, Vice-President, Policy, Research, Regulatory and Scientific Affairs Russell Williams, President

Canadian Generic Pharmaceutical Association Jim Keon, President

Department of Health Scott Doidge, Manager, Pharmacy Group, Non-Insured Health Benefits Directorate, First Nations and Inuit Health Branch Abby Hoffman, Executive Coordinator and Associate Assistant Deputy Minister, Pharmaceuticals Management Strategies, Health Policy Branch Ian Potter, Assistant Deputy Minister, First Nations and Inuit Health Branch	2007/04/23		49

Department of National Defence Lieutenant-Colonel Dave Cecillon, Pharmacy Policy and Standards

Department of Veterans Affairs Verna Bruce, Associate Deputy Minister and Chair of the Federal Healthcare Partnership

British Columbia Ministry of Health Robert Nakagawa, Assistant Deputy Minister, Pharmaceutical Services	2007/04/25		50

Canadian Agency for Drugs and Technologies in Health Braden Manns, Chair, Canadian Expert Drug Advisory Committee Jill M. Sanders, President and Chief Executive Officer

Canadian Agency for Drugs and Technologies in Health Mike Tierney, Vice-President, Common Drug Review	2007/04/25		50

Conference of Deputy Ministers of Health Ed Hunt, Chair of the Board of Directors, Canadian Agency for Drugs and Technologies in Health, and Assistant Deputy Minister, Department of Health and Community Services, Government of Newfoundland and Labrador John Wright, Co-Chair and Deputy Minister of Health, Government of Saskatchewan

Canadian Breast Cancer Network Diana Ermel, President Jackie Manthorne, Executive Director	2007/04/30		51

Cancer Advocacy Coalition of Canada William Hryniuk, Director and Past Chair

Cancer Care Ontario Debbie Milliken, Director, Provincial Drug Reimbursement Programs

Colorectal Cancer Association of Canada Barry D. Stein, President

Princess Margaret Hospital Jennifer Knox, Oncologist, University Health Network

Canadian Diabetes Association Michael Howlett, President and Chief Executive Officer Karen Philp, Vice-President, Public Policy	2007/05/02		52

Canadian Organization for Rare Disorders Durhane Wong-Rieger, President

The Fraser Institute Brett Skinner, Director, Pharmaceutical and Insurance Policy Research

Best Medicines Coalition Louise Binder, Chair Linda Wilhelm, Operations Committee member	2007/05/09		54

University of Toronto Janis Miyasaki, Associate Clinical Director and Chair of the Technology and Therapeutics Assessment Subcommittee, American Academy of Neurology

Ward Health Strategies Elisabeth Fowler, Vice-President, Health Policy

York University Joel Lexchin, Professor, School of Health Policy and Management

As individuals David Bougher, former member of the Federal, Provincial and Territorial Pharmaceutical Issues Committee Linda Tennant, former member of the Federal, Provincial and Territorial Pharmaceutical Issues Committee

Canadian Medical Association John Haggie, Chair, Board Working Group on Pharmaceutical Issues Briane Scharfstein, Associate Secretary General	2007/05/14		55

Hit the slope for hope Sarah Calvert, Spokesperson Michelle Calvert, Chair

Mood Disorders Society of Canada Phil Upshall, National Executive Director

St. Michael's Hospital Andreas Laupacis, Director, Li Ka Shing Knowledge Institute and former Chair of the Canadian Expert Drug Advisory Committee

University of Alberta Devidas Menon, Professor, School of Public Health	2007/05/16		56

University of British Columbia Steve Morgan, Assistant Professor, Centre for Health Services and Policy Research

As an individual Jean-Claude St-Onge, Author and Professor at Lionel-Groulx College

Canadian Agency for Drugs and Technologies in Health Jill M. Sanders, President and Chief Executive Officer	2007/06/06		60

Canadian Agency for Drugs and Technologies in Health Mike Tierney, Vice-President, Common Drug Review	2007/06/06		60

Conference of Deputy Ministers of Health John Wright, Co-Chair and Deputy Minister, Saskatchewan Health, Government of Saskatchewan